RIPK3 and neoplasm: Our results reveal a new necroptosis-mediated transcription circuit that is modulated by RIPK3 activation-dependent de-repression of TRIM28, which provides a mechanism to promote robust anti-tumor immunity and contributes to tumor immunogenicity.